UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients

Annals of hepatology, 2012-03, Vol.11 (2), p.179-185

2012

Volltextzugriff (PDF)

Review of boceprevir and telaprevir for the treatment of chronic hepatitis C

Canadian journal of gastroenterology, 2012-04, Vol.26 (4), p.205

2012

Volltextzugriff (PDF)

Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia

Canadian journal of gastroenterology & hepatology, 2015-03, Vol.29 (2), p.72-76

2015

Volltextzugriff (PDF)

Iron Overload Disorders: Treatment Options for Patients Refractory to or Intolerant of Phlebotomy

Pharmacotherapy, 2008-03, Vol.28 (3), p.331-342

2008

Volltextzugriff (PDF)

Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy

World journal of gastroenterology : WJG, 2005-09, Vol.11 (34), p.5392

2005

Volltextzugriff (PDF)

Erythropoietin and hepatitis C therapy: useful adjuvant therapy but remember to treat the patient and not just a number

Canadian journal of gastroenterology, 2006-08, Vol.20 (8), p.519

2006

Volltextzugriff (PDF)

Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis C

The Annals of pharmacotherapy, 2007-02, Vol.41 (2), p.268

2007

Volltextzugriff (PDF)

The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study

Anticancer research, 2014-07, Vol.34 (7), p.3597-3605

2014

Volltextzugriff (PDF)

The Authors respond

Canadian journal of gastroenterology & hepatology, 2015-05, Vol.29 (4), p.222-222

2015

Volltextzugriff (PDF)

Letters to the Editor

Canadian journal of gastroenterology & hepatology, 2015, Vol.29 (4), p.222-222

2015

Volltextzugriff (PDF)

Late Acute Rejection Occuring in Liver Allograft Recipients

Canadian journal of gastroenterology & hepatology, 1996-01, Vol.10 (6), p.376-380

1996

Volltextzugriff (PDF)

Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C

Liver international, 2022-04, Vol.42 (4), p.796-808

2022

Volltextzugriff (PDF)

Late acute rejection occurring in liver allograft recipients

Canadian journal of gastroenterology, 1996-10, Vol.10 (6), p.376

1996

Volltextzugriff (PDF)

Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment

Biomedicine & pharmacotherapy, 2021-11, Vol.143, p.112195-112195, Article 112195

2021

Volltextzugriff (PDF)

Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1419-1428

2020

Volltextzugriff (PDF)

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2011-04, Vol.305 (13), p.1305

2011

Volltextzugriff (PDF)

Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s Health Initiative

Stroke (1970), 2019-03, Vol.50 (3), p.555-562

2019

Volltextzugriff (PDF)

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

JAMA : the journal of the American Medical Association, 2010-10, Vol.304 (15), p.1684

2010

Volltextzugriff (PDF)

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

JAMA : the journal of the American Medical Association, 2009-01, Vol.301 (1), p.39

2009

Volltextzugriff (PDF)

On the joint role of non-Hispanic Black race/ethnicity and weight status in predicting postmenopausal weight gain

PloS one, 2021-03, Vol.16 (3), p.e0247821

2021

Volltextzugriff (PDF)

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

JAMA : the journal of the American Medical Association, 2006-02, Vol.295 (6), p.629

2006

Volltextzugriff (PDF)

Estrogen Therapy and Coronary-Artery Calcification

The New England journal of medicine, 2007-06, Vol.356 (25), p.2591-2602

2007

Volltextzugriff (PDF)

Prospective Study of Dairy Intake and the Risk of Type 2 Diabetes in Women

Diabetes care, 2006-07, Vol.29 (7), p.1579-1584

2006

Volltextzugriff (PDF)

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

JAMA : the journal of the American Medical Association, 2008-03, Vol.299 (9), p.1036

2008

Volltextzugriff (PDF)

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9697), p.1243-1251

2009

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(38)
Bücher
(1)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients

Review of boceprevir and telaprevir for the treatment of chronic hepatitis C

Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia

Iron Overload Disorders: Treatment Options for Patients Refractory to or Intolerant of Phlebotomy

Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy

Erythropoietin and hepatitis C therapy: useful adjuvant therapy but remember to treat the patient and not just a number

Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis C

The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study

The Authors respond

Letters to the Editor

Late Acute Rejection Occuring in Liver Allograft Recipients

Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C

Late acute rejection occurring in liver allograft recipients

Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment

Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s Health Initiative

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

On the joint role of non-Hispanic Black race/ethnicity and weight status in predicting postmenopausal weight gain

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

Estrogen Therapy and Coronary-Artery Calcification

Prospective Study of Dairy Intake and the Risk of Type 2 Diabetes in Women

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

Suchergebnisse filtern